Literature DB >> 387883

Direct immunofluorescence studies in alopecia areata and male pattern alopecia.

J C Bystryn, N Orentreich, F Stengel.   

Abstract

Direct immunofluroescence studies were performed on hairy and alopecic areas of scalp in patients with alopecia areata, alopecia totalis and male pattern alopecia. Abnormal deposits of C3 and occasionally of IgG and IgM were found in 92% of 12 patients with alopecia areata and in 21% of patients with male pattern alopecia. No abnormalities were seen in 4 patients with alopecia totalis. In both alopecia areata and male pattern alopecia, the deposits were most common along the basement zone of the inferior segment of hair follicles and occurred with equal frequency in alopecic and normal scalp. These observations suggest that immune factors may play a role in the pathogenesis of alopecia areata.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387883     DOI: 10.1111/1523-1747.ep12549703

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Suppressor cell decrease in alopecia areata.

Authors:  G N Ledesma; K K York
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

2.  Cell-mediated immunity in alopecia areata.

Authors:  R D'Ovidio; G A Vena; G Angelini
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

3.  In situ demonstration of T cells in alopecia areata.

Authors:  C Perret; E B Bröcker; L Wiesner-Menzel; R Happle
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Direct immunofluorescence pattern and histopathological staging in alopecia areata.

Authors:  Sai Kulkarni; Rajpal Singh Punia; Reetu Kundu; Gurvinder Pal Thami; Harsh Mohan
Journal:  Int J Trichology       Date:  2014-10

Review 5.  Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications.

Authors:  Shahnawaz D Jadeja; Desmond J Tobin
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.